Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingqiang Ren

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Plos One|September 6, 2007
Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acidGiulia Somenzi, Giusy Sala, Stefano Rossetti, et al.
International Journal of Cancer|June 25, 2017
Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomasJohn K Cowell, Haiyan Qin, Tianxiang Hu, et al.
Plos One|April 18, 2013
PGPIPN, a therapeutic hexapeptide, suppressed human ovarian cancer growth by targeting BCL2Wei Wang, Fang Gu, Cai Wei, et al.
Journal of Environmental Management|August 15, 2025
A review of the preparation, characterisation and application of electroactive membranes in water disinfectionTao Liu, Mingqiang Ren, Ziyi Zhang, et al.
Medicine|May 27, 2022
The transformation of isolated gastric myeloid sarcoma into acute myeloid leukemia presenting with a complex karyotype and TLS-ERG gene fusion: A case reportLu Gao, Yan Xu, Zuguo Tian, et al.
International Journal of Cancer|March 24, 2016
Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised miceMingqiang Ren, Haiyan Qin, Qing Wu, et al.
American Journal of Cancer Research|March 25, 2014
Sepantronium is a DNA damaging agent that synergizes with PLK1 inhibitor volasertibMei Hong, Mingqiang Ren, Jeane Silva, et al.
Oncotarget|July 9, 2016
SCLLTargeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine modelsQing Wu, Aaron Bhole, Haiyan Qin, et al.
Oncotarget|September 9, 2017
A combination of valproic acid sodium salt, CHIR99021, E-616452, tranylcypromine, and 3-Deazaneplanocin A causes stem cell-like characteristics in cancer cellsShuang Sha, Yuanfen Zhai, Chengzhao Lin, et al.
Nature Communications|March 6, 2019
Evidence of nematic order and nodal superconducting gap along [110] direction in RbFe<sub>2</sub>As<sub>2</sub>Xi Liu, Ran Tao, Mingqiang Ren, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Plos One|September 6, 2007
Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acidGiulia Somenzi, Giusy Sala, Stefano Rossetti, et al.
International Journal of Cancer|June 25, 2017
Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomasJohn K Cowell, Haiyan Qin, Tianxiang Hu, et al.
Plos One|April 18, 2013
PGPIPN, a therapeutic hexapeptide, suppressed human ovarian cancer growth by targeting BCL2Wei Wang, Fang Gu, Cai Wei, et al.
Journal of Environmental Management|August 15, 2025
A review of the preparation, characterisation and application of electroactive membranes in water disinfectionTao Liu, Mingqiang Ren, Ziyi Zhang, et al.
Medicine|May 27, 2022
The transformation of isolated gastric myeloid sarcoma into acute myeloid leukemia presenting with a complex karyotype and TLS-ERG gene fusion: A case reportLu Gao, Yan Xu, Zuguo Tian, et al.
International Journal of Cancer|March 24, 2016
Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised miceMingqiang Ren, Haiyan Qin, Qing Wu, et al.
American Journal of Cancer Research|March 25, 2014
Sepantronium is a DNA damaging agent that synergizes with PLK1 inhibitor volasertibMei Hong, Mingqiang Ren, Jeane Silva, et al.
Oncotarget|July 9, 2016
SCLLTargeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine modelsQing Wu, Aaron Bhole, Haiyan Qin, et al.
Oncotarget|September 9, 2017
A combination of valproic acid sodium salt, CHIR99021, E-616452, tranylcypromine, and 3-Deazaneplanocin A causes stem cell-like characteristics in cancer cellsShuang Sha, Yuanfen Zhai, Chengzhao Lin, et al.
Nature Communications|March 6, 2019
Evidence of nematic order and nodal superconducting gap along [110] direction in RbFe<sub>2</sub>As<sub>2</sub>Xi Liu, Ran Tao, Mingqiang Ren, et al.
Pageof 5